Aldeyra Therapeutics Provides Update on NS2 Clinical Program
March 02, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference
February 23, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Abstracts Accepted for Presentation at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology
February 02, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Present Novel Data on a Potential Treatment for Sjogren-Larsson Syndrome at the 2015 Society for Inherited Metabolic Disorders Annual Meeting
January 29, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Participate in Canaccord Genuity Rare Disease, BioPharma One-on-One Day
January 26, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Completes $2.0 Million Private Placement
January 22, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Announces $2.0 Million Private Placement
January 20, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Completes $7.79 Million Private Placement
January 15, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Announces $7.79 Million Private Placement
January 13, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 13, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Submits IND Filing to FDA for Clinical Testing of NS2 in Patients With Sjogren-Larsson Syndrome
January 05, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...